BFM
TBIO

Boothbay Fund Management’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Boothbay Fund Management’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-10,100
Closed -$101K – 1161
2020
Q1 		$101K Buy
+10,100
New +$82.7K 0.01% 725
2019
Q3 		– Sell
-15,790
Closed -$199K – 966
2019
Q2 		$199K Buy
+15,790
New +$166K 0.02% 622

Other funds holding TBIO

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AVA
Atlas Venture Advisors Boston, Massachusetts $122M AUM 26.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Boothbay Fund Management's TBIO Position: Q2 2020 in Review

Boothbay Fund Management sold out of Translate Bio, Inc. Common Stock (TBIO) in Q2 2020, closing a stake of 10,100 shares — an estimated $101K sold.

Boothbay Fund Management first reported a position in TBIO in Q2 2019 and held it in 2 quarters. The position peaked at $199K in Q2 2019. 133 funds tracked by Wall St. Rank hold TBIO as of Q2 2020.

  • Boothbay Fund Management reported no remaining Translate Bio, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Boothbay Fund Management sold 10,100 Translate Bio, Inc. Common Stock shares in Q2 2020, an estimated $101K.
  • Boothbay Fund Management first reported a position in Translate Bio, Inc. Common Stock in Q2 2019 and held it in 2 quarters.
  • Boothbay Fund Management's Translate Bio, Inc. Common Stock position peaked at $199K in Q2 2019.
  • 133 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q2 2020.

Based on Boothbay Fund Management's 13F filing for Q2 2020, filed 14 Aug 2020.